Okimoto Clinic

Matsumoto, H., Tsukamoto, M., Okimoto, N. et al. Author's Response to letter to the editor "Commentary on: the effects of sequential therapy using anti-resorptive agents after administering once-weekly teriparatide or twice-weekly teriparatide” (JBMM-D-26–00062). J Bone Miner Metab (2026). https://doi.org/10.1007/s00774-026-01717-z Anyone you share the following link with will be able to read this content: Sorry, a shareable link is not currently available for this article.

Abstract Initiating osteoporosis medication within 3 months after fracture reduces secondary fractures, particularly hip fractures, in individuals aged ≥ 75 years. This finding highlights the importance of early and sustained treatment in older populations. To evaluate the efficacy of initiating osteoporosis medication within 3 months after a fracture and continuing it for at least 6 months in preventing secondary fractures among individuals aged ≥ 75 years.

References 1. LoCascio V, Bonucci E, Imbimbo B, Ballanti P, Adami S, Milani S, Tartarotti D, DellaRocca C (1990) Bone loss in response to long-term glucocorticoid therapy. Bone Miner 8(1):39–51. https://doi.org/10.1016/0169-6009(91)90139-q CAS Article PubMed Google Scholar 2. Laan RF, van Riel PL, van de Putte LB, van Erning LJ, van’t Hof MA, Lemmens JA, (1993) Low-dose prednisone induces rapid reversible axial bone loss in patients with rheumatoid arthritis. A randomized, controlled study.